Literature DB >> 19352285

Pulmonary tumor thrombotic microangiopathy: FDG-PET/CT findings.

Yoshiko Tashima1, Koichiro Abe, Yoshio Matsuo, Shingo Baba, Koichiro Kaneko, Takuro Isoda, Hidetake Yabuuchi, Masayuki Sasaki, Hiroshi Honda.   

Abstract

Pulmonary tumor thrombotic microangiopathy (PTTM) is histopathologically characterized by proliferation of intimal myofibroblasts in the small pulmonary arterioles, induced by tumor microemboli. Patients develop rapidly progressive and severe cardiopulmonary failure, and the clinical course of this disease is fatal. Conventional radiologic findings are often minimal or nonspecific, making diagnosis difficult before death. We report 2-(F-18)-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) images of PTTM, which illustrate the characteristic findings of this clinical entity. FDG-PET can be helpful for the diagnosis of PTTM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352285     DOI: 10.1097/RLU.0b013e3181966f5c

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  9 in total

1.  Pulmonary tumour thrombotic microangiopathy as a cause of new-onset pulmonary hypertension in a patient with metastatic low-grade serous ovarian cancer.

Authors:  Scott L Purga; Navneet Narula; Evelyn M Horn; Maria G Karas
Journal:  BMJ Case Rep       Date:  2015-08-26

2.  Pulmonary tumor thrombotic microangiopathy from metastatic epithelioid angiosarcoma.

Authors:  Funda Demirag; Ebru Cakir; Ulku Yazici; Irfan Tastepe
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

3.  Pulmonary tumor thrombotic microangiopathy in an unknown primary cancer.

Authors:  Gayathri P Amonkar; Kusum D Jashnani; Sandhya Pallewad
Journal:  Lung India       Date:  2014-10

4.  Echocardiographic Assessment of Patients with Pulmonary Tumor Thrombotic Microangiopathy First Diagnosed in the Emergency Department.

Authors:  Minjoo Kim; Hee Yoon; Min Yeong Kim; Ik Joon Jo; Soo Yeon Kang; Guntak Lee; Jong Eun Park; Taerim Kim; Se Uk Lee; Sung Yeon Hwang; Won Chul Cha; Tae Gun Shin
Journal:  Diagnostics (Basel)       Date:  2022-01-20

5.  Pulmonary tumor thrombotic microangiopathy with thrombus in pulmonary artery caused by diffuse sclerosing variant of thyroid papillary adenocarcinoma: A case report.

Authors:  Masahiro Yoshida; Shiro Adachi; Itsumure Nishiyama; Kenichiro Yasuda; Ryo Imai; Yoshihisa Nakano; Yuta Tsuyuki; Deoksu Kim; Takahisa Kondo; Toyoaki Murohara
Journal:  Pulm Circ       Date:  2022-01-12       Impact factor: 2.886

6.  Pulmonary tumor thrombotic microangiopathy from metastatic prostate carcinoma.

Authors:  Dhruv Nayyar; Kavitha Muthiah; Christopher S Hayward; Zerlene Lim; Emily K Granger; Mark Nicholls; Allan R Glanville
Journal:  Case Rep Pulmonol       Date:  2015-01-06

7.  Pulmonary Tumor Thrombotic Microangiopathy: Clinical, Radiologic, and Histologic Correlation.

Authors:  Rohit Godbole; Abhijeet Ghatol; Jamie Betancourt; John Sacoolidge; Nader Kamangar
Journal:  J Clin Imaging Sci       Date:  2015-07-31

8.  Pulmonary tumor thrombotic microangiopathy caused by prostate carcinoma.

Authors:  Daisuke Katayama; Keiko Kuriyama; Tatsuya Kinoshita; Keisuke Nagai; Hidenari Hongyo; Kentaro Kishimoto; Atsuo Inoue; Manabu Takamura; Soomi Choi
Journal:  Acta Radiol Open       Date:  2016-08-24

9.  Pulmonary Tumor Thrombotic Microangiopathy Caused by a Parotid Tumor: Early Antemortem Diagnosis and Long-term Survival.

Authors:  Haruka Toyonaga; Michiko Tsuchiya; Chikara Sakaguchi; Hitomi Ajimizu; Yosuke Nakanishi; Seiya Nishiyama; Noboru Morikawa; Yasuyuki Hayashi; Yukio Nagasaka; Hiroshi Yasui
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.